alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
STATE of Louisiana v. Tracy Lee MCMOOAIN

No. 2018-KH-0345

Supreme Court of Louisiana.

February 25, 2019

**ON SUPERVISORY WRITS TO THE TWENTY-SECOND JUDICIAL DISTRICT COURT, PARISH OF ST. TAMMANY**

PER CURIAM:

Denied. Applicant's sentencing claim is not cognizable on collateral review. La.C.Cr.P. art. 930.3 ; *State ex rel. Melinie v. State* , 93-1380 (La. 1/12/96), 665 So.2d 1172 ; *see also* *State v. Cotton* , 09-2397 (La. 10/15/10), 45 So.3d 1030. Applicant also fails to show that he received ineffective assistance of counsel under the standard of *Strickland v. Washington* , 466 U.S. 668, 104 S.Ct. 2052, 80 L.Ed.2d 674 (1984). As *435to his remaining claims, applicant fails to satisfy his post-conviction burden of proof. La.C.Cr.P. art. 930.2.

Applicant has now fully litigated his application for post-conviction relief in state court. Similar to federal habeas relief, *see* 28 U.S.C. § 2244, Louisiana post-conviction procedure envisions the filing of a second or successive application only under the narrow circumstances provided in La.C.Cr.P. art. 930.4 and within the limitations period as set out in La.C.Cr.P. art. 930.8. Notably, the legislature in 2013 La. Acts 251 amended that article to make the procedural bars against successive filings mandatory. Applicant's claims have now been fully litigated in accord with La.C.Cr.P. art. 930.6, and this denial is final. Hereafter, unless he can show that one of the narrow exceptions authorizing the filing of a successive application applies, applicant has exhausted his right to state collateral review. The district court is ordered to record a minute entry consistent with this per curiam.

Hughes, J., would grant the writ for an evidentiary hearing.
III 

118TH CONGRESS 

1ST SESSION S. RES. 270 

Designating July 15, 2023, as ‘‘National Leiomyosarcoma Awareness Day’’. 

IN THE SENATE OF THE UNITED STATES 

JUNE 22, 2023 

Ms. STABENOW submitted the following resolution; which was referred to the 

Committee on the Judiciary 

RESOLUTION 

Designating July 15, 2023, as ‘‘National Leiomyosarcoma 

Awareness Day’’. 

Whereas leiomyosarcoma is a malignant sarcoma subtype, 

one of 70 to 100 such subtypes, that arises in smooth 

muscle and has several subtypes itself due to its vascularity and bone invasion; 

Whereas leiomyosarcoma is designated by the National Institutes of Health as a rare form of cancer; 

Whereas leiomyosarcoma is largely resistant to standard 

chemotherapy treatments, radiation treatments, and 

immunotherapy trials, with 40-year-old chemotherapy 

treatments still in use; 

Whereas leiomyosarcoma affects all age groups, including 

children, young adults, the middle-aged, and the elderly, 

and all genders; 


kjohnson on DSK79L0C42PROD with BILLS
2 

•SRES 270 IS 

Whereas leiomyosarcoma is diagnosed in more than 2,000 individuals in the United States each year; 

Whereas, with respect to leiomyosarcoma, research and clinical trials remain complicated and extremely costly due to 

the difficulty of recruiting patients; 

Whereas survival and longevity for individuals with 

leiomyosarcoma has not significantly improved for at 

least 30 years; 

Whereas multidisciplinary care coordination teams, because 

of their expertise and experience, are critical to the 

health of leiomyosarcoma patients; 

Whereas researchers continue to strive to improve quality of 

life for leiomyosarcoma patients, improve outcomes in 

clinical trials, and promote enhanced survivorship; and 

Whereas increased education and awareness about sarcoma 

and leiomyosarcoma will contribute to the well-being of 

the communities of the United States: Now, therefore, be 

it 

1 Resolved, That the Senate— 

2 (1) designates July 15, 2023, as ‘‘National 

3 Leiomyosarcoma Awareness Day’’; 

4 (2) recognizes the challenges faced by 

5 leiomyosarcoma patients; and 

6 (3) commends the dedication of organizations, 

7 volunteers, researchers, and caregivers across the 

8 United States working to improve the quality of life 

9 of leiomyosarcoma patients and their families. 

Æ 


kjohnson on DSK79L0C42PROD with BILLS
Tarrance Terrell MAYS v. STATE

CR-16-0801

Court of Criminal Appeals of Alabama.

August 4, 2017 Reh. denied September 1, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5

<S>                             <C>                     <C>
<PERIOD-TYPE>                   6-MOS                   YEAR
<FISCAL-YEAR-END>                          DEC-31-2000             DEC-31-1999
<PERIOD-START>                             JAN-01-2000             JAN-01-1999
<PERIOD-END>                               JUN-30-2000             DEC-31-1999
<CASH>                                          74,240                 774,911
<SECURITIES>                                         0                       0
<RECEIVABLES>                                        0                       0
<ALLOWANCES>                                         0                       0
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                                80,266                 794,911
<PP&E>                                         454,768                   5,369
<DEPRECIATION>                                (30,271)                    (79)
<TOTAL-ASSETS>                                 795,186                 875,333
<CURRENT-LIABILITIES>                          629,961               1,033,996
<BONDS>                                              0                       0
<PREFERRED-MANDATORY>                                0                       0
<PREFERRED>                                          0                       0
<COMMON>                                        27,568                   9,640
<OTHER-SE>                                     137,657               (168,303)
<TOTAL-LIABILITY-AND-EQUITY>                   795,186                 875,333
<SALES>                                              0                       0
<TOTAL-REVENUES>                                     0                       0
<CGS>                                                0                       0
<TOTAL-COSTS>                                        0                       0
<OTHER-EXPENSES>                             1,699,926                 945,086
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                               7,122                   5,149
<INCOME-PRETAX>                            (1,688,243)               (939,097)
<INCOME-TAX>                               (1,688,243)               (939,097)
<INCOME-CONTINUING>                                  0                       0
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                               (1,688,243)               (939,097)
<EPS-BASIC>                                    (0.060)                 (0.030)
<EPS-DILUTED>                                  (0.060)                 (0.030)


</TABLE>
Randy Lee MATKINS v. STATE

CR-16-0996

Court of Criminal Appeals of Alabama.

September 20, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Reh. denied.
<PAGE>

                                  EXHIBIT 10.17

April 28, 2004

Board of Directors
SulphCo, Inc.
850 Spice Islands Dr.
Sparks, NV  89431

Gentlemen:

SulphCo, Inc. (OTC Bulletin Board: SLPH) announced today that its Chairman and
CEO, Dr. Rudolf W. Gunnerman, has made a commitment to continue to finance
SulphCo up to $2,000,000.00, as required. This commitment is expected to satisfy
the financial requirements of the Company at least through the 2004 fiscal year.


Sincerely,

/s/ Rudolf W. Gunnerman

Rudolf W. Gunnerman
Chairman





--------------------------------------------------------------------------------
            SulphCo, Inc., 850 Spice Islands Drive, Sparks, NV 89431
        Voice: (775) 829-1310 Fax: (775) 829-1351 Email: info@sulphco.com
[ EXHIBIT 31.2 ]

                                 CERTIFICATION

I, James Young, certify that:

1. I have reviewed this first amended annual report on Form 10-KSB of Perfect
Health Care Corp.;

2. Based on my knowledge, this annual report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this annual
report;

3. Based on my knowledge, the financial statements, and other financial
information included in this annual report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this annual report;

4. The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

         a) designed such disclosure controls and procedures to ensure that
         material information relating to the registrant, including its
         consolidated subsidiaries, is made known to us by others within those
         entities, particularly during the period in which this annual report is
         being prepared;

         b) evaluated the effectiveness of the registrant's disclosure controls
         and procedures as of a date within 90 days prior to the filing date of
         this annual report (the "Evaluation Date"); and

         c) presented in this annual report our conclusions about the
         effectiveness of the disclosure controls and procedures based on our
         evaluation as of the Evaluation Date;

5. The registrant's other certifying officers and I have disclosed, based on our
most recent evaluation, to the registrant's auditors and the audit committee of
registrant's board of directors (or persons performing the equivalent function):

         a) all significant deficiencies in the design or operation of internal
         controls which could adversely affect the registrant's ability to
         record, process, summarize and report financial data and have
         identified for the registrant's auditors any material weaknesses in
         internal controls; and

         b) any fraud, whether or not material, that involves management or
         other employees who have a significant role in the registrant's
         internal controls; and

6. The registrant's other certifying officers and I have indicated in this
annual report whether or not there were significant changes in internal controls
or in other factors that could significantly affect internal controls subsequent
to the date of our most recent evaluation, including any corrective actions with
regard to significant deficiencies and material weaknesses.


Date: November 12, 2004

/s/ James W. Young
-------------------------
Chief Financial Officer
<PAGE>

                                  EXHIBIT 13.2

                            CERTIFICATION PURSUANT TO
                 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the annual report of Galen Holdings PLC (the
"Company") on Form 20-F for the fiscal year ended September 30, 2003 as filed
with the Securities and Exchange Commission on the date hereof (the "Report"),
I, R. Geoffrey Elliott, Chief Financial Officer of the Company, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:

         1. The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

         2. The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.

Date: January 5, 2004

/s/ R.Geoffrey Elliott
------------------------------
Name: R. Geoffrey Elliott
Title: Chief Financial Officer

                                       9
```

[Federal Register Volume 89, Number 249 (Monday, December 30, 2024)]
[Notices]
[Page 106549]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-31195]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Institute of Neurological Disorders and Stroke; Notice 
of Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel; Clinical Trials in Neurology 
(III).
    Date: January 17, 2025.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate cooperative agreement 
applications.
    Address: National Institutes of Health, Neuroscience Center, 
6001 Executive Boulevard, Rockville, MD 20852.
    Meeting Format: Virtual Meeting.
    Contact Person: Shanta Rajaram, Ph.D., Scientific Review 
Officer, Scientific Review Branch, Division of Extramural 
Activities, NINDS/NIH/DHHS, NSC, 6001 Executive Boulevard, 
Rockville, MD 20852, 301-435-6033, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS)

    Dated: December 20, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee 
Policy.
[FR Doc. 2024-31195 Filed 12-27-24; 8:45 am]
BILLING CODE 4140-01-P
```
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 5 Agreed to Senate (ATS)]

<DOC>

118th CONGRESS
  1st Session
S. RES. 5

 Notifying the House of Representatives of the election of a President 
                              pro tempore.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            January 3, 2023

 Mr. Schumer submitted the following resolution; which was considered 
                             and agreed to

_______________________________________________________________________

                               RESOLUTION

 
 Notifying the House of Representatives of the election of a President 
                              pro tempore.

    Resolved, That the House of Representatives be notified of the 
election of the Honorable Patty Murray as President of the Senate pro 
tempore.
                                 <all>
```
## Breadcrumb

-  Home 

# Explore Search: Geology General

Filters

              - products_publications(2)
              - (-)multimedia_audio(1)
              - multimedia_audio-141766(1)
              - multimedia_image(1)
              - multimedia_image-141771(1)
              - multimedia_video(2)
              - multimedia_video-149194(2)

## By Location

              - alaska(3)
              - arizona(1)
              - california(2)
              - colorado(1)
              - florida(1)
              - louisiana(2)
              - michigan(1)
              - (-)minnesota(1)
              - oregon(2)
              - south carolina(3)
              - south dakota(24)
              - virginia(2)

## By Year

Podcasts        October 31, 2010        Endocrine Disruptors and Intersex Fish in Minnesota Lakes
David Tramine JONES v. STATE

CR-16-0213

Court of Criminal Appeals of Alabama.

September 1, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
<PAGE>

                                                                    EXHIBIT 99.1

(CITIZENS FIRST NATIONAL BANK LOGO)

                                   MEMORANDUM

To:      Princeton National Bancorp Board of Directors and Executive Officers

From:    Jill S. Smith
         SVP/Human Resources

Date:    April 24, 2006

Subject: Blackout Period for Princeton National Bancorp Common Shares

     From May 25, 2006 through the week of June 19, 2006, you will be prohibited
from purchasing, selling or otherwise acquiring or transferring Princeton
National Bancorp common shares if you acquired such security in connection with
your service to or employment with Princeton National Bancorp or Citizens First
National Bank. As explained in more detail below, this prohibition is imposed by
Section 306 of the Sarbanes-Oxley Act of 2002 and the rules promulgated
thereunder by the Securities and Exchange Commission commonly referred to as
Regulation BTR (Blackout Trading Restriction).

     By way of background, Section 306(a) of the Sarbanes-Oxley Act prohibits
directors and executive officers of an issuer from trading in the issuer's
equity securities during any period during which employees are unable to
purchase or sell issuer equity securities held in 401(k) or similar plans. This
period is commonly referred to as a "blackout period." A blackout period is
usually imposed for administrative reasons such as changes in plan record
keepers, introduction of new investment alternatives or business combinations.

     The Citizens First National Bank 401(k) & Profit Sharing Plan is changing
its record keeper to ADP Retirement Services. As a result of this change, from
May 25, 2006 through the week of June 19, 2006, the record keepers require
certain Plan activity to cease so that assets and account balances may be
properly transferred. During this blackout period, Plan participants will be
unable to change current investment elections and reallocate account balances.
Under these circumstances, because Princeton National Bancorp common shares are
an investment option under the Plan, pursuant to Section 306 of the
Sarbanes-Oxley Act of 2002, directors and executive officers are prohibited from
trading in Princeton National Bancorp common shares acquired in connection with
service to or employment with Princeton National Bancorp or Citizens First
National Bank.

     If you have any questions regarding the upcoming blackout period and your
ability to purchase, sell or otherwise transfer Princeton National Bancorp
common shares, please contact Jill Smith, SVP-Human Resources or Tammy Humpage,
AVP & Employee Benefits Manager at (815) 875-4444.


                                        5
IN THE SUPREME COURT OF THE STATE OF MONTANA No. DA 1 9
- 0585 STATE OF MONTANA,

Plaintiff and Appellee,

v. ALVIAN ERR EV

Y MARQUEZ , Defendant and Appellant.

**ORDER** Upon consideration of c ounsel’s motion to withdraw as counsel of record, and good cause appearing, IT IS HEREBY ORDERED that the Defendan t and Appellant in this matter shall file a response to this motion within thirty ( 30 ) days of the date of this Order. The response must be served upon all counsel of record, including the Attorney Ge neral, the County Attorney, and the Appellate Defender Division’s Office. IT IS FURTHER ORDERED that the Clerk of this Court give notice of this Order by mail to all counsel of record and to the Defendant and Appellant at his last known address.

Electronically signed by: Mike McGrath Chief Justice, Montana Supreme Court

November 2 2020

11/02/2020

Case Number: DA 19-0585
NUMBER 13

- 10

- 00 080

- CR



### COURT OF APPEALS

THIRTEENTH DISTRICT OF TEXAS

CORPUS CHRISTI

- EDINBURG

___________________________________________________________

DAVINA CLAY

, Appellant,

v.

THE STATE OF TEXAS, Appellee.

____________________________________________________________

On a ppeal from the 117t h District Court

of Nueces County, Texas.

____________________________________________________________



### MEMORANDUM OPINION

Before Chief Justice Valdez and Justices Rodriguez and Vela

Memorandum Opinion Per Curiam

Appellant, Davina Clay , by and through h er attorney, has filed a motion to dismiss

h er appeal because s he no longer desires to prosecute it. See T EX

. R. A PP

. P . 42.2(a).

Without passing o n the merits of the case, we grant the motion to dismiss pursuant to

Texas Rule of Appellate Procedure 42.2(a) and dismiss the appeal. Having dismissed2

the appeal at appellant's request, no motion for rehearing will be entertained, and our

mandate will is sue forthwith. Any pending motions are dismissed as moot.

PER CURIAM

Do not publish. See T EX

. R. A PP

. P . 47.2(b).

D elivered and filed the 18th

day of November, 2010

.
Jorge A. CASTRO a/k/a Jorge Castro a/k/a Jorge Castro, III, and Leonor Dominguez, Appellants, v. NATIONSTAR MORTGAGE, LLC, Appellee.

No. 4D17-3622

District Court of Appeal of Florida, Fourth District.

[February 14, 2019]

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
The STREMS LAW FIRM, P.A., Hunter Patterson, Esq. and Alicia Perez, Esq., Appellant/Petitioner(s), v. AMERICAN SECURITY INSURANCE COMPANY and Brenda Rodriguez, Appellee/Respondent(s).

CASE NO.: 2D18-5021

District Court of Appeal of Florida, Second District.

February 26, 2019

**DECISION WITHOUT PUBLISHED OPINION**

Appeal is dismissed.

Denied. Denied.
THE THIRTEENTH COURT OF APPEALS

13-12-00676-CR

JOSE SANTOS CASAS

v.

THE STATE OF TEXAS

On Appeal from the

357th District Court of Cameron County, Texas

Trial Cause No. 2012-DCR-2570-E

JUDGMENT

THE THIRTEENTH COURT OF APPEALS, having considered this cause on 

appeal, concludes that the judgment of the trial court should be AFFIRMED. The Court 

orders the judgment of the trial court AFFIRMED.

We further order this decision certified below for observance.

April 24, 2014
# C_2020262EN.01001801.xml

| 10.8.2020 | EN | Official Journal of the European Union | C 262/18 |
| --- | --- | --- | --- |

10.8.2020

EN

Official Journal of the European Union

C 262/18

---

Request for a preliminary ruling from the Korkein hallinto-oikeus (Finland) lodged on 28 May 2020 — B Oy

(Case C-223/20)

(2020/C 262/23)

Language of the case: Finnish

Referring court

Korkein hallinto-oikeus

Parties to the main proceedings

Appellant: B Oy

Other party: Veronsaajien oikeudenvalvontayksikkö

Questions referred

| 1. | Is Article 4 of Directive 92/83/EEC (1) to be interpreted as meaning that a Member State which applies reduced rates of excise duty to beer produced by independent small breweries pursuant to that provision must also apply the provision on the joint taxation of small breweries contained in the second sentence of Article 4(2) of that directive, or is the application of the latter provision left to the discretion of the Member State concerned? |
| --- | --- |

1.

Is Article 4 of Directive 92/83/EEC (1) to be interpreted as meaning that a Member State which applies reduced rates of excise duty to beer produced by independent small breweries pursuant to that provision must also apply the provision on the joint taxation of small breweries contained in the second sentence of Article 4(2) of that directive, or is the application of the latter provision left to the discretion of the Member State concerned?

| 2. | Does the second sentence of Article 4(2) of Directive 92/83/EEC have direct effect? |
| --- | --- |

2.

Does the second sentence of Article 4(2) of Directive 92/83/EEC have direct effect?

---

(1)  Council Directive 92/83/EEC of 19 October 1992 on the harmonisation of the structures of excise duties on alcohol and alcoholic beverages (OJ 1992 L 316, p. 21).

---